These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 18663226)

  • 1. Effective inhibition in animals of viral pathogenesis by a ribozyme derived from RNase P catalytic RNA.
    Bai Y; Trang P; Li H; Kim K; Zhou T; Liu F
    Proc Natl Acad Sci U S A; 2008 Aug; 105(31):10919-24. PubMed ID: 18663226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catalytic M1GS RNA as an antiviral agent in animals.
    Bai Y; Rider PJ; Liu F
    Methods Mol Biol; 2010; 629():339-53. PubMed ID: 20387160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral delivery of RNase P ribozymes by Salmonella inhibits viral infection in mice.
    Bai Y; Gong H; Li H; Vu GP; Lu S; Liu F
    Proc Natl Acad Sci U S A; 2011 Feb; 108(8):3222-7. PubMed ID: 21300908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNase P ribozyme inhibits cytomegalovirus replication by blocking the expression of viral capsid proteins.
    Kim K; Trang P; Umamoto S; Hai R; Liu F
    Nucleic Acids Res; 2004; 32(11):3427-34. PubMed ID: 15220469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNase P Ribozymes Inhibit the Replication of Human Cytomegalovirus by Targeting Essential Viral Capsid Proteins.
    Yang Z; Reeves M; Ye J; Trang P; Zhu L; Sheng J; Wang Y; Zen K; Wu J; Liu F
    Viruses; 2015 Jun; 7(7):3345-60. PubMed ID: 26114473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracellular expression of engineered RNase P ribozymes effectively blocks gene expression and replication of human cytomegalovirus.
    Kim K; Umamoto S; Trang P; Hai R; Liu F
    RNA; 2004 Mar; 10(3):438-47. PubMed ID: 14970389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of hepatitis C virus by an M1GS ribozyme derived from the catalytic RNA subunit of Escherichia coli RNase P.
    Mao X; Li X; Mao X; Huang Z; Zhang C; Zhang W; Wu J; Li G
    Virol J; 2014 May; 11():86. PubMed ID: 24885776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNase P ribozymes for the studies and treatment of human cytomegalovirus infections.
    Trang P; Kilani A; Lee J; Hsu A; Liou K; Kim J; Nassi A; Kim K; Liu F
    J Clin Virol; 2002 Aug; 25 Suppl 2():S63-74. PubMed ID: 12361758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salmonella-mediated delivery of RNase P-based ribozymes for inhibition of viral gene expression and replication in human cells.
    Bai Y; Li H; Vu GP; Gong H; Umamoto S; Zhou T; Lu S; Liu F
    Proc Natl Acad Sci U S A; 2010 Apr; 107(16):7269-74. PubMed ID: 20360564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineered RNase P Ribozymes Effectively Inhibit the Infection of Murine Cytomegalovirus in Animals.
    Li W; Liu Y; Wang Y; Li R; Trang P; Tang W; Yang Z; Wang Y; Sun X; Xing X; Lu S; Liu F
    Theranostics; 2018; 8(20):5634-5644. PubMed ID: 30555569
    [No Abstract]   [Full Text] [Related]  

  • 11. Expression of an RNase P ribozyme against the mRNA encoding human cytomegalovirus protease inhibits viral capsid protein processing and growth.
    Trang P; Kim K; Zhu J; Liu F
    J Mol Biol; 2003 May; 328(5):1123-35. PubMed ID: 12729746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective inhibition of human cytomegalovirus gene expression and replication by a ribozyme derived from the catalytic RNA subunit of RNase P from Escherichia coli.
    Trang P; Lee M; Nepomuceno E; Kim J; Zhu H; Liu F
    Proc Natl Acad Sci U S A; 2000 May; 97(11):5812-7. PubMed ID: 10811889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineered RNase P ribozymes are efficient in cleaving a human cytomegalovirus mRNA in vitro and are effective in inhibiting viral gene expression and growth in human cells.
    Zou H; Lee J; Umamoto S; Kilani AF; Kim J; Trang P; Zhou T; Liu F
    J Biol Chem; 2003 Sep; 278(39):37265-74. PubMed ID: 12867424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Determination of the in vitro antiviral activity of an engineered M1GS ribozyme that targets to the core gene of hepatitis C virus].
    Zhang W; Li X; Luo G; Huang Z; Liu Y
    Wei Sheng Wu Xue Bao; 2013 Aug; 53(8):875-81. PubMed ID: 24341280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effective inhibition of human immunodeficiency virus 1 replication by engineered RNase P ribozyme.
    Zeng W; Chen YC; Bai Y; Trang P; Vu GP; Lu S; Wu J; Liu F
    PLoS One; 2012; 7(12):e51855. PubMed ID: 23300569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting mRNAs by engineered sequence-specific RNase P ribozymes.
    Bai Y; Sunkara N; Liu F
    Methods Mol Biol; 2012; 848():357-68. PubMed ID: 22315080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effective inhibition of herpes simplex virus 1 gene expression and growth by engineered RNase P ribozyme.
    Trang P; Lee J; Kilani AF; Kim J; Liu F
    Nucleic Acids Res; 2001 Dec; 29(24):5071-8. PubMed ID: 11812839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineering of RNase P Ribozymes for Therapy against Human Cytomegalovirus Infection.
    Smith A; Zhang I; Trang P; Liu F
    Viruses; 2024 Jul; 16(8):. PubMed ID: 39205170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developing RNase P ribozymes for gene-targeting and antiviral therapy.
    Trang P; Kim K; Liu F
    Cell Microbiol; 2004 Jun; 6(6):499-508. PubMed ID: 15104592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissecting human cytomegalovirus gene function and capsid maturation by ribozyme targeting and electron cryomicroscopy.
    Yu X; Trang P; Shah S; Atanasov I; Kim YH; Bai Y; Zhou ZH; Liu F
    Proc Natl Acad Sci U S A; 2005 May; 102(20):7103-8. PubMed ID: 15883374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.